MRC Clinical Trials Unit at UCL
Institute of Clinical Trials & Methodology
90 High Holborn
2nd Floor
London
WC1V 6LJ
Email. mrcctu.radicals@ucl.ac.uk
When radiotherapy is used after surgery for prostate cancer, it can be given either alone or together with hormone therapy. Both approaches are commonly used in the UK. We do not know which is better and, if it is better to use hormone therapy, we don’t know for how long it should be given. RADICALS will test whether men receiving radiotherapy after surgery also need hormone therapy.
In the Hormone Duration Comparison men are divided into three groups:
This is the design of the Hormone Duration Comparison:
RADICALS
MRC Clinical Trials Unit at UCL
Institute of Clinical Trials & Methodology
90 High Holborn
2nd Floor
London
WC1V 6LJ
Email. mrcctu.radicals@ucl.ac.uk